[Stimulating and hypobiotic therapy in cardiogenic shock].
Comparative evaluation of the efficacy of stimulating and hypobiotic agents in 122 dogs with experimentally induced cardiogenic shock and 56 patients with acute myocardial infarction complicated by cardiogenic shock allowed a relationship to be established of the efficiency of therapeutic measures to the phase and rate of progression of the pathological process. In rapid progression of clinical symptoms of cardiogenic shock it is predominantly preparations of hypobiotic action that are to be prescribed whereas in slow progression of these it is advisable to use agents of stimulating action.
V A
VA
Bobrov
N I
NI
Shved
D M
DM
Sherman
D000818:Animals; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004285:Dogs; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D002316:Cardiotonic Agents; D002317:Cardiovascular Agents
Stimuliruiushchaia i gipobioticheskaia terapiia pri kardiogennom shoke.